Novavax (NVAX)
(Delayed Data from NSDQ)
$9.35 USD
-0.26 (-2.71%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $9.42 +0.07 (0.75%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$9.35 USD
-0.26 (-2.71%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $9.42 +0.07 (0.75%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
Zacks News
5 Breakout Stocks Offering Phenomenal Returns
by Swarup Gupta
This approach involves homing in on stocks trading within a tight range and buying them when they step out of this band.
Can The Uptrend Continue for Novavax (NVAX)?
by Zacks Equity Research
Investors certainly have to be happy with Novavax, Inc. (NVAX) and its short term performance
Implied Volatility Surging for Novavax (NVAX) Stock Options
by Zacks Equity Research
Options traders are pricing in a big move for Novavax (NVAX) shares as it has huge implied volatility.
Are Options Traders Betting on a Big Move in Novavax (NVAX) Stock?
by Zacks Equity Research
Options traders are pricing in a big move for Novavax, Inc. (NVAX) shares as it has huge implied volatility.
Lessons Of A Biotech Blowup
by Brian Bolan
Biotechs are risky plays, even for the "smart money"